Short Interest in Celularity Inc. (NASDAQ:CELUW) Rises By 51.3%

Celularity Inc. (NASDAQ:CELUW) was the target of a large growth in short interest during the month of January. As of January 15th, there was short interest totaling 3,393 shares, a growth of 51.3% from the December 31st total of 2,243 shares. Based on an average daily trading volume, of 2,351 shares, the short-interest ratio is presently 1.4 days. Based on an average daily trading volume, of 2,351 shares, the short-interest ratio is presently 1.4 days.

Celularity Trading Down 48.9%

Celularity stock traded down $0.01 during mid-day trading on Friday, hitting $0.01. The company’s stock had a trading volume of 195,265 shares, compared to its average volume of 17,511. The stock’s fifty day moving average is $0.02 and its two-hundred day moving average is $0.03. Celularity has a 1 year low of $0.01 and a 1 year high of $0.75.

About Celularity

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.